Company Filing History:
Years Active: 2019
Title: The Innovative Contributions of Christian Elabd
Introduction
Christian Elabd is a notable inventor based in Berkeley, California. He has made significant strides in the field of molecular compositions aimed at enhancing and rejuvenating the maintenance and repair of mammalian tissues. His work is particularly relevant in the context of muscle and neural cell regeneration.
Latest Patents
Elabd holds a patent for a molecular composition that involves methods, pharmaceutical compositions, and kits designed for treating subjects with effective amounts of an oxytocin receptor (OXTR) agonist and an ALK5 antagonist. This innovative approach may utilize oxytocin or its analogs as the OXTR agonist, while the ALK5 antagonist may include various small molecules such as 2-(3-(6-Methyl-pyridin-2-yl)-1H-pyrazol-4-yl)-1,5-naphthyridine, LY2157299, A 83-01, D 4476, GW 788388, LY 364947, Rep Sox, SB 431542, SB 505124, SB 525334, or SD 208. The amounts of these compounds are designed to induce muscle regeneration and/or neural cell regeneration in subjects.
Career Highlights
Elabd is affiliated with the University of California, where he continues to contribute to research and innovation in his field. His work has garnered attention for its potential applications in regenerative medicine.
Collaborations
Elabd has collaborated with esteemed colleagues such as Irina M Conboy and David V Schaffer, further enhancing the impact of his research through teamwork and shared expertise.
Conclusion
Christian Elabd's innovative work in molecular compositions represents a significant advancement in the field of regenerative medicine. His contributions have the potential to improve treatment options for muscle and neural cell regeneration, showcasing the importance of research and collaboration in scientific progress.